Eli Lilly and (LLY) Revenue — Quarter Ended Mar 31, 2025
Revenue declined from the preceding quarter, partially reversing the robust growth seen over the past year. Compared with the same period a year earlier, revenue continued to show a strong increase.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q1
Revenue declined from the preceding quarter, partially reversing the robust growth seen over the past year. Compared with the same period a year earlier, revenue continued to show a strong increase.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$12.7B
Revenue reported for this quarter.
Quarter-over-quarter
-5.9%
Change from the immediately preceding quarter.
Year-over-year
+45.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$49B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $11.3B | +36.0% |
| Sep 30, 2024 | $11.4B | +20.4% |
| Dec 31, 2024 | $13.5B | +44.7% |
| Mar 31, 2025 | $12.7B | +45.2% |
Revenue performance
The reported revenue for the quarter was lower than the immediately preceding quarter, breaking a streak of sequential gains. On an annual basis, however, revenue remained significantly higher than the year-ago level.
Quarterly comparison
Compared with the previous quarter, revenue decreased, while compared with the same quarter one year earlier, revenue rose substantially. This pattern reflects a temporary pullback after a period of accelerated growth.
What to watch
Monitor whether the sequential decline continues in the coming quarters or if growth resumes.